HL Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

HL Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,379	Closed	-$230K	–	679
2016 Q3	$230K	Buy	+2,379	New	+$226K	0.01%	598
2015 Q3	–	Sell	-32,460	Closed	-$3.99M	–	652
2015 Q2	$3.99M	Buy	32,460 +30,690	+1,734%	+$3.67M	0.11%	130
2015 Q1	$203K	Sell	1,770 -921	-34%	-$102K	0.01%	658
2014 Q4	$272K	Buy	+2,691	New	+$262K	0.01%	575
2014 Q1	–	Sell	-3,186	Closed	-$241K	–	654
2013 Q4	$241K	Buy	+3,186	New	+$226K	0.01%	564

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HL Financial Services's IBB Position: Q4 2016 in Review

HL Financial Services sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 2,379 shares — an estimated $230K sold.

HL Financial Services first reported a position in IBB in Q4 2013 and held it in 5 quarters. The position peaked at $3.99M in Q2 2015. 523 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

HL Financial Services reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
HL Financial Services sold 2,379 iShares Biotechnology ETF shares in Q4 2016, an estimated $230K.
HL Financial Services first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 5 quarters.
HL Financial Services's iShares Biotechnology ETF position peaked at $3.99M in Q2 2015.
523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on HL Financial Services's 13F filing for Q4 2016, filed 31 Jan 2017.